Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-27

Clinical Trial Update: BOTOX® (Onabotulinumtoxin A) Injection(s) as a Treatment for Carpal Tunnel Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating Botox (onabotulinumtoxinA) injections for treatment of carpal tunnel syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Benjamin Sucher | Conditions: Carpal Tunnel Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-09-27